RhumbLine Advisers
CAH icon

RhumbLine Advisers’s Cardinal Health CAH Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$104M Sell
619,413
-41,954
-6% -$7.05M 0.09% 186
2025
Q1
$91.1M Buy
661,367
+35,312
+6% +$4.86M 0.09% 204
2024
Q4
$74M Sell
626,055
-20,859
-3% -$2.47M 0.07% 236
2024
Q3
$71.5M Sell
646,914
-50,630
-7% -$5.6M 0.06% 255
2024
Q2
$68.6M Buy
697,544
+52,716
+8% +$5.18M 0.06% 253
2024
Q1
$72.2M Buy
644,828
+80,789
+14% +$9.04M 0.07% 247
2023
Q4
$56.9M Sell
564,039
-41,707
-7% -$4.2M 0.06% 286
2023
Q3
$52.6M Sell
605,746
-5,217
-0.9% -$453K 0.06% 275
2023
Q2
$57.8M Buy
610,963
+21,073
+4% +$1.99M 0.06% 267
2023
Q1
$44.5M Sell
589,890
-59,351
-9% -$4.48M 0.06% 316
2022
Q4
$49.9M Buy
649,241
+45,742
+8% +$3.52M 0.07% 269
2022
Q3
$40.2M Buy
603,499
+28,757
+5% +$1.92M 0.06% 293
2022
Q2
$30M Sell
574,742
-51,439
-8% -$2.69M 0.04% 373
2022
Q1
$35.5M Buy
626,181
+9,504
+2% +$539K 0.05% 349
2021
Q4
$31.8M Sell
616,677
-19,028
-3% -$980K 0.04% 407
2021
Q3
$31.4M Sell
635,705
-11,457
-2% -$567K 0.04% 382
2021
Q2
$36.9M Sell
647,162
-16,965
-3% -$969K 0.05% 341
2021
Q1
$40.3M Sell
664,127
-21,281
-3% -$1.29M 0.05% 301
2020
Q4
$36.7M Buy
685,408
+11,122
+2% +$596K 0.05% 319
2020
Q3
$31.7M Buy
674,286
+2,852
+0.4% +$134K 0.05% 331
2020
Q2
$35M Buy
671,434
+60,555
+10% +$3.16M 0.06% 296
2020
Q1
$29.3M Buy
610,879
+41,994
+7% +$2.01M 0.06% 277
2019
Q4
$28.8M Buy
568,885
+26,800
+5% +$1.36M 0.05% 350
2019
Q3
$25.6M Buy
542,085
+29,291
+6% +$1.38M 0.05% 367
2019
Q2
$24.2M Buy
512,794
+11,697
+2% +$551K 0.05% 390
2019
Q1
$24.1M Sell
501,097
-32,152
-6% -$1.55M 0.05% 371
2018
Q4
$23.8M Sell
533,249
-5,418
-1% -$242K 0.05% 342
2018
Q3
$29.1M Sell
538,667
-11,759
-2% -$635K 0.06% 332
2018
Q2
$26.9M Sell
550,426
-16,044
-3% -$783K 0.05% 345
2018
Q1
$35.5M Sell
566,470
-8,607
-1% -$539K 0.07% 267
2017
Q4
$35.2M Buy
575,077
+15,549
+3% +$953K 0.07% 274
2017
Q3
$37.4M Buy
559,528
+13,168
+2% +$881K 0.08% 251
2017
Q2
$42.6M Buy
546,360
+16,467
+3% +$1.28M 0.1% 221
2017
Q1
$43.2M Buy
529,893
+4,597
+0.9% +$375K 0.1% 211
2016
Q4
$37.8M Buy
525,296
+21,485
+4% +$1.55M 0.1% 218
2016
Q3
$39.1M Buy
503,811
+3,174
+0.6% +$247K 0.11% 199
2016
Q2
$39.1M Buy
500,637
+16,147
+3% +$1.26M 0.12% 183
2016
Q1
$39.7M Buy
484,490
+16,471
+4% +$1.35M 0.12% 165
2015
Q4
$41.8M Sell
468,019
-2,627
-0.6% -$235K 0.13% 149
2015
Q3
$36.2M Buy
470,646
+4,830
+1% +$371K 0.12% 168
2015
Q2
$39M Buy
465,816
+32,224
+7% +$2.7M 0.12% 165
2015
Q1
$39.1M Sell
433,592
-8,430
-2% -$761K 0.11% 179
2014
Q4
$35.7M Buy
442,022
+1,024
+0.2% +$82.7K 0.1% 191
2014
Q3
$33M Sell
440,998
-17,794
-4% -$1.33M 0.1% 196
2014
Q2
$31.5M Sell
458,792
-5,110
-1% -$350K 0.09% 205
2014
Q1
$32.5M Sell
463,902
-102,105
-18% -$7.15M 0.1% 194
2013
Q4
$37.8M Sell
566,007
-13,669
-2% -$913K 0.11% 179
2013
Q3
$30.2M Buy
579,676
+7,219
+1% +$376K 0.09% 200
2013
Q2
$27M Buy
+572,457
New +$27M 0.09% 219